Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Reviewing your finances regularly is essential for success. Explore various ways to conduct reviews and enhance your financial strategy.
18,365 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
As KBR prepares to unveil its Q4 2025 results, investors should focus on backlog, margins, and free cash flow. This g...
Volatility can create buying opportunities. Here's one hypergrowth tech stock 2026 pick that blends AI momentum, scal...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
March 2026 brings a wave of Koyfin alternatives as traders seek deeper data, faster alerts, and cleaner interfaces. H...
In a volatile market, three names stand out for reliable income: Realty Income, EPR Properties, and Verizon. Each del...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
New SSA data shows benefits rise with age, peaking after delaying retirement credits. But even at 70, many retireesSt...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
A growing number of high-income workers are using in-plan roth conversion high strategies within 401(K) plans to dodg...
A wave of AI compute demand is reshaping the chip landscape. While Cerebras eyes an IPO, the market shows that strong...